Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

Aller à Demande

1. WO2021242877 - IDENTIFICATION DU RISQUE D'ŒDÈME CÉRÉBRAL

Numéro de publication WO/2021/242877
Date de publication 02.12.2021
N° de la demande internationale PCT/US2021/034279
Date du dépôt international 26.05.2021
CIB
G01N 33/68 2006.1
GPHYSIQUE
01MÉTROLOGIE; TESTS
NRECHERCHE OU ANALYSE DES MATÉRIAUX PAR DÉTERMINATION DE LEURS PROPRIÉTÉS CHIMIQUES OU PHYSIQUES
33Recherche ou analyse des matériaux par des méthodes spécifiques non couvertes par les groupes G01N1/-G01N31/146
48Matériau biologique, p.ex. sang, urine; Hémocytomètres
50Analyse chimique de matériau biologique, p.ex. de sang ou d'urine; Test par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligands; Test immunologique
68faisant intervenir des protéines, peptides ou amino-acides
CPC
G01N 2333/4724
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
2333Assays involving biological materials from specific organisms or of a specific nature
435from animals; from humans
46from vertebrates
47Assays involving proteins of known structure or function as defined in the subgroups
4701Details
4724Lectins
G01N 2333/523
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
2333Assays involving biological materials from specific organisms or of a specific nature
435from animals; from humans
52Assays involving cytokines
521Chemokines
523Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1or LDCF-2
G01N 2333/7155
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
2333Assays involving biological materials from specific organisms or of a specific nature
435from animals; from humans
705Assays involving receptors, cell surface antigens or cell surface determinants
715for cytokines; for lymphokines; for interferons
7155for interleukins [IL]
G01N 2800/2871
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
2800Detection or diagnosis of diseases
28Neurological disorders
2871Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
G01N 2800/50
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
2800Detection or diagnosis of diseases
50Determining the risk of developing a disease
G01N 33/6893
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
68involving proteins, peptides or amino acids
6893related to diseases not provided for elsewhere
Déposants
  • UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION [US]/[US]
Inventeurs
  • PENNYPACKER, Keith R.
  • FRASER, Justin F.
  • CHENG, Qiang
Mandataires
  • DECKER, Mandy Wilson
  • HAEBERLIN, Jeffrey
  • HAYNE, James
  • MYERS JR., Richard S
  • NAGLE, JR., David
  • RITCHIE, Sean P.
  • STEWART, Gary N.
  • WEYER, Stephen J.
  • WRIGHT, Terry
Données relatives à la priorité
63/030,25926.05.2020US
Langue de publication Anglais (en)
Langue de dépôt anglais (EN)
États désignés
Titre
(EN) IDENTIFYING RISK OF CEREBRA EDEMA
(FR) IDENTIFICATION DU RISQUE D'ŒDÈME CÉRÉBRAL
Abrégé
(EN) Tools for identifying risk of cerebral edema in a stroke patient are provided and include a method that involves identifying risk of cerebral edema when cytokines and chemokines are detected in a systemic blood sample from the subject.
(FR) L'invention concerne des outils pour identifier un risque d'œdème cérébral chez un patient souffrant d'accident vasculaire cérébral qui comprennent une méthode impliquant l'identification d'un risque d'œdème cérébral lorsque des cytokines et des chimiokines sont détectées dans un échantillon de sang systémique provenant du sujet.
Dernières données bibliographiques dont dispose le Bureau international